Search - tctmd.com

January 06, 2026

News Daily News

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

December 26, 2025

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

December 23, 2025

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

News Features

Year in Review: Women’s Heart Health in the Spotlight

December 23, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

December 12, 2025

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

December 10, 2025

News Daily News

Reversal of Childhood Overweight May Prevent Later CHD Risks

Todd Neale

December 03, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

November 24, 2025

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

November 21, 2025

News Daily News

Online Calculator Allows Young Adults to See How Their 30-Year CV Risk Compares to Peers’

November 19, 2025

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Todd Neale

November 14, 2025

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

November 14, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

November 13, 2025

News Daily News

Fish Oil Halves CV Risk in Patients on Dialysis: PISCES

November 10, 2025

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

November 08, 2025

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

November 08, 2025

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

November 07, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

November 04, 2025

News Daily News

Cardiologists Saw Rising Incomes but Additional Pressures in 2024: MedAxiom